ALTAN PHARMACEUTICALS, S.A.
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 2
- Shared contracts
- 2 (multi-supplier framework agreements)
- Period
- 12 August 2026 – 21 August 2026
Its main clients
Where and what
Supplies · 2
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 10 August 2027 re-tender around February 2027 |
Suministro de Trastuzumab (DOE) intravenoso, Micofenolato de Mofetilo (DOE), Acido Micofenolico (DOE), Dexmedetomidina (DOE) y Aztreonam (DOE)
OSAKIDETZA - Servicio Vasco de Salud - Organización Central |
BIOCON BIOLOGICS SPAIN S.L. ALTAN PHARMACEUTICALS, S.A. B. BRAUN MEDICAL, S.A. 3 bids received |
€544,000 |
| 18 August 2027 re-tender around February 2027 |
Suministro de Sorafenib (DOE), Ibuprofeno (DOE) pediátrico intravenoso, Nitisinona (DOE) suspensión, Fentanilo (DOE) transdérmico y Paracetamol (DOE)
OSAKIDETZA - Servicio Vasco de Salud - Organización Central |
VIATRIS PHARMACEUTICALS, S.L. B. BRAUN MEDICAL, S.A. SWEDISH ORPHAN BIOVITRUM S L TEVA PHARMA, S.L. FERRER FARMA, S.A. ALTAN PHARMACEUTICALS, S.A. 3 bids received |
€775,739 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.